Spirometers Market Size
|Market Size (2023)||USD 568.96 Million|
|Market Size (2028)||USD 758.89 Million|
|CAGR (2023 - 2028)||5.93 %|
|Fastest Growing Market||Asia-Pacific|
|Largest Market||North America|
*Disclaimer: Major Players sorted in no particular order
Need a report that reflects how COVID-19 has impacted this market and its growth?
Spirometers Market Analysis
The Spirometers Market size is expected to grow from USD 568.96 million in 2023 to USD 758.89 million by 2028, at a CAGR of 5.93% during the forecast period (2023-2028).
COVID-19 impacted the growth of the spirometer market owing to the decline in the diagnosis and treatment of patients suffering from respiratory diseases. For instance, according to the research study published in Elsevier Public Health Emergency, September 2021, it has been observed that the use of spirometry is restricted to immunocompromised patients for urgent treatment only, such as bone marrow transplants, lung transplants, and pre-chemotherapy treatments. Also, according to the research study published in PLOS One in February 2021, it has been observed that the risk for all-cause mortality is approximately two times higher in patients with COPD than in those without COPD, and a steep decline in visits to hospitals and clinics due to the lockdown measures imposed by the government has severely impacted the market growth during a pandemic. However, resumed diagnosis and treatment services for respiratory diseases and increased patient visits have increased market growth, are expected to regain their potential over the years, and may record healthy growth during the forecast period.
Factors such as the rise in the prevalence of chronic obstructive pulmonary disease (COPD), technological advancements in the field of spirometers, and a growing preference for home healthcare are boosting market growth.
The rising burden of COPD among the population raises the need for early detection of the COPD condition, which is expected to fuel the demand for spirometry tests. This is anticipated to augment market growth over the forecast period. For instance, as per an article published in the European Respiratory Journal, in November 2021, about 49,453,852 Europeans are expected to suffer from COPD by 2050, as compared to 36,580,965 in 2020. In addition, as per the same source, the Netherlands is expected to have the highest prevalence of COPD (14.6%) in Europe by 2050.
Additionally, according to the study published in PLOS ONE in January 2021, in France, there are currently 2.6 million people who have chronic obstructive pulmonary disease (COPD), and by 2025, that number is expected to rise to 2.8 million. Also, as per the 2022 statistics published by the NHS, about 1.17 million people in England were diagnosed with chronic obstructive pulmonary disorder (COPD) in 2020–2021, accounting for 1.9% of the total population. Thus, the expected increase in the number of people suffering from COPD is expected to increase the demand for technologically advanced spirometers, hence propelling market growth.
Furthermore, technological advances and the increasing portability and ease of operation of devices are anticipated to drive segment growth. For instance, in March 2021, Vyaire Medical launched the AioCare (HealthUp SA, Poland) mobile spirometry system in more than 15 countries, including Australia and other countries. This clinically proven technology expands upon Vyaire's deep respiratory diagnostics expertise and allows physicians to promptly diagnose pulmonary diseases including asthma and COPD as accurately as hospital-grade spirometers.
Moreover, the preference for home healthcare has increased among patients, which has increased the development of tele-spirometers or virtual spirometry tests, which is also contributing to the market's growth. For instance, in June 2021, eResearch Technology (ERT) launched ERT iSpiro Virtual Visits, which enables real-time coaching during at-home pulmonary function tests (PFT). iSpiro Virtual Visits makes it possible to gather high-quality spirometry data at home, keeping respiratory clinical studies on schedule, even when a patient is unable to visit a clinic.
Therefore, owing to the aforementioned factors, the studied market is expected to grow over the forecast period. But not enough people know about chronic obstructive pulmonary disease (COPD), which is likely to slow the growth of the spirometer market over the next few years.
Spirometers Industry Segmentation
As per the scope of the report, a spirometer is a medical device that is used to measure the proper functioning of the lungs, where the volume of air inhaled and exhaled from the lungs is measured after maximum inhalation by the patient. A spirometer helps in the identification of different respiratory diseases, such as bronchitis, chronic lung diseases that are obstructive, emphysema, asthma, and other breathing diseases, for screening in an occupational environment. A spirometer is used to analyze lung function before surgery and predict respiratory diseases. The spirometers market is segmented by type (hand-held and table-top), technology (volume measurement and flow measurement), application (asthma, COPD, cystic fibrosis, and others), end-user (hospitals and clinics and home healthcare), and geography (North America, Europe, Asia-Pacific, the Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.
|Hospitals and Clinics|
Spirometers Market Trends
This section covers the major market trends shaping the Spirometers Market according to our research experts:
Hand-Held is Expected to Witness Significant Growth in the Spirometers Market
The hand-held spirometers segment is expected to witness significant growth in the spirometers market over the forecast period owing to factors such as the increasing number of COPD and asthma cases, the growing number of smokers across the globe, and increasing product launches.
Hand-held spirometers are small, lightweight, and easily portable, thereby becoming more ubiquitous in the industry. The advantages of hand-held spirometers over conventional spirometers, such as being easy to use and being able to be used outside the hospital setting too, are expected to augment segment growth.
According to an article published in Primary Care Respiratory Medicine in April 2022, the accuracy of three portable spirometers, the PIKO-6, COPD-6, and PEF, was determined. It has been observed that the accuracy of PIKO-6 was higher (0.95) than that of COPD-6 (0.91) and PEF (0.82). In addition, as per the same source, portable spirometers, such as the PIKO-6 and COPD-6, can provide a variety of respiratory function indicators that aid in the diagnosis of COPD patients, as well as in determining the severity of the condition and assisting in the selection of an effective treatment strategy. Thus, portable spirometers are ideal for primary care use and offer a practical method for the early detection of COPD due to their high accuracy, user-friendliness, patient-friendliness, affordability, and portability. This is expected to increase their adoption among patients, hence propelling the segment’s growth.
Furthermore, the rising company activities and increasing product launches are also expected to increase the availability of hand-held spirometer devices, which in turn is anticipated to fuel the segment's growth. For instance, in November 2021, Cipla launched a pneumotach-based portable, wireless spirometer in India. With this launch, the company intends to revolutionize obstructive airway disease (OAD) diagnosis, in line with its ambition to strengthen its position as the lung leader in India.
Therefore, owing to the aforementioned factors, such as the growing number of smokers, the increasing burden of COPD, and increasing product launches, the studied segment is expected to grow over the forecast period.
To understand key trends, Download Sample Report
North America is Expected to Have the Significant Market Share Over the Forecast Period
North America is expected to witness healthy growth in the spirometer market over the forecast period. The factors contributing to market growth are the rising prevalence and incidences of respiratory diseases, the presence of a well-established healthcare infrastructure along with high healthcare spending, and the growing adoption of home-health devices among consumers.
The rising burden of respiratory diseases such as asthma, COPD, and others is expected to increase the demand for spirometers, thereby boosting market growth. For instance, according to the Asthma and Allergy Foundation of America (AAFA), in April 2022, roughly 1 in 13 Americans had asthma, which is about 25 million people. According to the same source, about 5.1 million American children have asthma under the age of 18. The same source stated that asthma is more common in female adults than in male adults.
Furthermore, the United States is under pressure to reduce the burden of respiratory disease, and the economic impact is significant.For instance, in an article published in the International Journal of COPD in March 2021, the researchers estimated that the annual direct costs of COPD in the United States are USD 18 billion and are expected to reach USD 22 billion by 2030.
Furthermore, the rise in the number of initiatives undertaken by government and non-government organizations is increasing overall revenue. For instance, the CDC’s National Asthma Control Program (NACP) provides funds for educating asthma-affected patients. Such initiatives are likely to increase awareness about asthma, which will increase the adoption of spirometry tests, which in turn is anticipated to augment market growth over the forecast period.
Moreover, the increasing product approvals and launches in the region are also contributing to market growth. For instance, in April 2021, Vitalograph launched a next-generation Pneumotrac spirometer in the United States. The Pneumotrac spirometer is integrated with Spirotrac PC software and is a powerful tool for respiratory diagnosis in both adults and pediatrics.
Therefore, owing to factors such as the high burden of respiratory diseases and increasing product approvals, the studied market is expected to grow in the North America region over the forecast period.
To understand geography trends, Download Sample Report
Spirometers Industry Overview
The spirometer market is moderately fragmented and consists of several major players. There has been a significant presence of companies that are significantly contributing to the market's growth. Product innovation and ongoing R&D activities to develop advanced technologies have helped boost the growth of the market. Some of the major players in the market are MGC Diagnostics Corporation, NDD Medical Technologies, KoKo PFT, Koninklijke Philips N.V., and ICU Medical, Inc., among others.
Spirometers Market Leaders
MGC Diagnostics Corporation
NDD Medical Technologies
ICU Medical, Inc.
Koninklijke Philips N.V.
*Disclaimer: Major Players sorted in no particular order
Spirometers Market News
- September 2022: RxCap, Inc. entered into a partnership with ZEPHYRx to integrate the ZEPHYRx cloud spirometry platform with RxCap's remote monitoring platform. This enables RxCap's enterprise customers, such as providers and payers, to monitor the lung function of their patients and members with serious pulmonary conditions.
- August 2022: AstraZeneca partnered with Alveofit, a respiratory healthcare platform, to offer IoT-enabled handheld spirometers at hospitals across the country. This handheld spirometer is connected to the Internet of Things (IoT), so it can be used to track patients remotely and do tele-spirometry with full care management solutions.
Spirometers Market Report - Table of Contents
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in Prevalence of Chronic Obstructive Pulmonary Disease (COPD)
4.2.2 Technological Advancements in the Field Of Spirometers
4.2.3 Growing Preference for Home Healthcare
4.3 Market Restraints
4.3.1 Lack of Awareness regarding Chronic Obstructive Pulmonary Disease (COPD)
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 By Type
5.2 By Technology
5.2.1 Volume Measurement
5.2.2 Flow Measurement
5.3 By Application
5.3.3 Cystic Fibrosis
5.3.4 Other Applications
5.4 By End-User
5.4.1 Hospitals and Clinics
5.4.2 Home Healthcare
5.5.1 North America
126.96.36.199 United States
188.8.131.52 United Kingdom
184.108.40.206 Rest of Europe
220.127.116.11 South Korea
18.104.22.168 Rest of Asia-Pacific
5.5.4 Middle East and Africa
22.214.171.124 South Africa
126.96.36.199 Rest of Middle East and Africa
5.5.5 South America
188.8.131.52 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Baxter International (Hill-Rom Services, Inc)
6.1.2 Jones Medical Instrument Company
6.1.3 MGC Diagnostics Corporation
6.1.4 Midmark Corporation
6.1.5 NDD Medical Technologies
6.1.6 KoKo PFT
6.1.7 OHD (SCHAUENBURG International Group)
6.1.8 Koninklijke Philips N.V.
6.1.9 ICU Medical, Inc.
6.1.10 Teleflex Incorporated
6.1.12 Vyaire Medical Inc.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Spirometers Market Research FAQs
How big is the Spirometers Market?
The Spirometers Market size is expected to reach USD 568.96 million in 2023 and grow at a CAGR of 5.93% to reach USD 758.89 million by 2028.
What is the current Spirometers Market size?
In 2023, the Spirometers Market size is expected to reach USD 568.96 million.
Who are the key players in Spirometers Market?
MGC Diagnostics Corporation, NDD Medical Technologies, KoKo PFT, ICU Medical, Inc. and Koninklijke Philips N.V. are the major companies operating in the Spirometers Market.
Which is the fastest growing region in Spirometers Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2023-2028).
Which region has the biggest share in Spirometers Market?
In 2023, the North America accounts for the largest market share in the Spirometers Market.
Spirometers Industry Report
Statistics for the 2023 Spirometers market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Spirometers analysis includes a market forecast outlook to 2028 and historical overview. Get a sample of this industry analysis as a free report PDF download.